ARCHIVE

• BULLETIN
  March 3, 2003

• Indications of Antibacterials to Be Reevaluated
  March 3, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  March 3, 2003

• REPORT
  March 3, 2003

• REGULATORY NEWS IN BRIEF
  March 3, 2003

• WEBSITE NEWS
  March 3, 2003

• Meet the Leaders (16)
  March 3, 2003

• Takeda Discovers Novel Mechanism of Insulin Secretion
  March 3, 2003

• Fujisawa Licenses GPCR Drug Target from TaiGen
  March 3, 2003

• Shionogi Expects Sharp Recovery from FY2003
  March 3, 2003

• Kaken to Codevelop Antifungals with Elitra of the US
  March 3, 2003

• NBI's AII Receptor Antagonist Micardis Off to Strong Start
  March 3, 2003

• Global CRO Market Grew to US$7 Billion in 2001: 6th Nomura Bioconference
  March 3, 2003

• Dainippon Introduces New System to Boost R&D Efficiency
  March 3, 2003

• ESRI Report Recommends Unification of Social Insurance Programs
  February 24, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  February 24, 2003

• Overseas Growth a Major Priority: Kyorin's President
  February 24, 2003

• National Burden Rate to Drop to 36.1% in FY2003
  February 24, 2003

• Matsumotokiyoshi Ties Up with Itayama Medico of Yamanashi
  February 24, 2003

• 10 Wholesalers to Be Surcharged for Violation of Antimonopoly Act
  February 24, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 615
• 616
• 617
• 618
• 619
• 620
• 621
• 622
• 623
• …
• Next ›
• 最終 »